









Markets
/
Stocks
/
nasdaq-pdex
/

Pro-Dex Inc

PDEX

46.890USD

-2.410-4.89%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

153.44MMarket Cap

13.47P/E TTM



Pro-Dex Inc

46.890

-2.410-4.89%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Pro-Dex Inc

Currency: USD Updated: 2026-03-27

Key Insights

Pro-Dex Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 127 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 56.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pro-Dex Inc's Score

Industry at a Glance

Industry Ranking

127 / 208

Overall Ranking

301 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Pro-Dex Inc Highlights

StrengthsRisks

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 44.49% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 66.59M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 66.59M.

Fairly Valued

The company’s latest PE is 14.07, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.01M shares, decreasing 22.27% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 1.82K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.56.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

56.000

Target Price

+13.59%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Pro-Dex Inc is 8.95, ranking 10 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 18.66M, representing a year-over-year increase of 11.14%, while its net profit experienced a year-over-year increase of 7.21%.

Score

Industry at a Glance

Previous score

8.95

Change



Financials

9.40

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.85

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.68

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.81

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Pro-Dex Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Pro-Dex Inc is 6.77, ranking 148 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 14.07, which is 231.84% below the recent high of 46.70 and 49.81% above the recent low of 7.06.

Score

Industry at a Glance

Previous score

6.77

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 127/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

No earnings forecast score is currently available for Pro-Dex Inc. The Healthcare Equipment & Supplies industry's average is 7.78. The average price target is 56.00, with a high of 56.00 and a low of 56.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

56.000

Target Price

+14.33%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Pro-Dex Inc

PDEX

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Pro-Dex Inc is 9.24, ranking 3 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 52.86 and the support level at 44.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.32

Change

-0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.471

Neutral

RSI(14)

53.381

Neutral

STOCH(KDJ)(9,3,3)

50.986

Sell

ATR(14)

3.224

Low Volatility

CCI(14)

-42.640

Neutral

Williams %R

53.517

Neutral

TRIX(12,20)

0.605

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

48.864

Sell

MA10

48.678

Sell

MA20

47.772

Sell

MA50

43.380

Buy

MA100

40.640

Buy

MA200

40.221

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Pro-Dex Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 31.47%, representing a quarter-over-quarter decrease of 4.38%. The largest institutional shareholder is The Vanguard, holding a total of 144.57K shares, representing 4.51% of shares outstanding, with 12.72% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Swenson (Nicholas John)

1.02M

+0.10%

Farnam Street Capital, Inc.

270.85K

-3.20%

BlackRock Institutional Trust Company, N.A.

144.93K

+6.45%

The Vanguard Group, Inc.

Star Investors

146.14K

-0.02%

Van Kirk (Richard Lee Jr)

98.71K

-0.07%

Dimensional Fund Advisors, L.P.

62.53K

Punch & Associates Investment Management, Inc.

48.61K

+42.13%

Geode Capital Management, L.L.C.

49.50K

-4.20%

Northern Trust Investments, Inc.

40.46K

-8.95%

J.P. Morgan Securities LLC

33.53K

-3.87%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Pro-Dex Inc is 2.81, ranking 143 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.10. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.